As of April 7th, there are over 1,390,511 infected cases of coronavirus around the world according to the John Hopkins interactive tool. Thus far there haven’t been any drugs to specifically treat coronavirus. Many doctors around the world are trying to treat infected with anti-malaria drugs and also AIDS drugs. The same protocols were used during SARS.
Russian scientists in collaboration with Belarusian researchers proposed a new class of drugs that will aid in the treatment of cancerous tumors. The drugs proposed are based on using palladium and platinum. The class of drugs based on platinum derivatives is now considered one of the most effective in the fight against tumors.
The most common of them in clinical practice is cisplatin that contains a heavy metal complex with a central atom of platinum surrounded by two chloride atoms and two ammonia molecules in the cis position. It is a white powder with the molecular formula PtCl2H6N2, and a molecular weight of 300.05. However, its poor water solubility and high toxicity led to the development of new anticancer drugs based on platinum group metal compounds.
A mystery behind the Tretyakov gallery painting has been solved in a study published in the Heritage Science Journal. Tretyakov Art Gallery is an extensive museum complex containing masterpieces of Russian art from the 11th – early 20th century, temporary exhibitions, educational and cultural programs. The Tretyakov Art Gallery has an exclusive collection of unique Russian art. It was founded by the Moscow merchant and industrialist Pavel Mikhailovich Tretyakov (1832-1898).
A monthly performance review of Durig’s high yielding Fixed Income 2 (FX2) Managed Income Portfolio which also explores the many benefits that the portfolio can provide to investors.
- Over 6% in Cash Generation Alone
- Year-to-Date Return of 6.20%
- Trailing 1 Year Return of 7.72%
- Trailing 3 Year Return of 9.03%
- Trailing 5 Year Return of 9.13%
- Annualized Return Since Inception of 8.72%
- Average Bond Maturity of 4 Years
- Alpha of 10.58 (vs. Benchmark)*
- Beta of -1.22 (vs. Benchmark)*
- Excess Return of 4.32% (vs. Benchmark)*
This review looks at the performance of the Dogs of the Dow Portfolio which produces over 4% in dividend income alone, and also examines the benefits the portfolio can provide to income investors.
- Annualized Return Since Inception of 12.32%
- Average Dividend Yield of 4.03%
- Alpha of 1.89 (vs. Benchmark*)
- Beta of 0.77 (vs. Benchmark*)
Designed for the Long Term
The Dogs of the Dow Portfolio was designed to produce high levels of dividend income over time with less volatility than the stock market. With an average dividend yield of over 4% alone and a lifetime return of over 12%, the Dogs of the Dow’s effectiveness over the years lies in both its repeatability and scalability.
Though the stocks in Durig’s Dogs of the Dow Portfolio more than likely will change from year to year, the underlying screens used to select them remain the same.
Durig searches for and selects a group of of the highest yielding dividend stocks from the Dow Jones Industrial Average (DJIA) which have fallen out of favor (aka the “dogs”) and holds them for one year. Over time, these “dogs” tend to have “more room to run” with respect to their share price.
Time in the market nearly always beats timing the market.
Durig’s Dogs of the Dow is a simple, yet effective strategy that was specifically designed to earn you more income by capturing the dividends of some of the highest yielding blue chip stocks of the Dow Jones. Over time, reinvested dividends can help to boost total return and potentially grow the dividend income the portfolio produces.
Why Blue Chip Dividend Stocks?
Historically, blue chip dividend stocks have shown themselves to be resilient under downward market pressure, and are thought to offer relative stability in hectic markets as compared to non-dividend paying stocks. Additionally, companies that pay dividends tend to have much stronger fundamentals, such as stable earnings and growth, effective management and stronger financials.
The dividends paid by blue chips can also help to diversify income streams, and because dividends (and earnings) tend to grow over time they typically outpace inflation, preserving the value of your hard earned dollars. These dividends can also help to lessen historical volatility, explained in a recent article:
“During the overall market downturn in 2002, when non dividend-paying stocks fell by an average of 30%, while dividend-paying stocks only declined on average by 10%. Even during the severe 2008 financial crisis that precipitated a sharp fall in stock prices, dividend stocks held up noticeably better than non dividend stocks.”
Less historical volatility equates to a smoother and more comfortable ride for investors.
Durig’s Dogs of the Dow Portfolio can be extremely efficient in a tax advantaged account (such as an IRA) since neither capital gains nor dividends are taxed, allowing your investment to grow tax-free.
Avoid the Crowd
The majority of blue chip investors find themselves in an overly crowded mutual fund structure. While it may seem nice to share gains and losses but in actuality pooled investments are far more muddled, and typically more costly due to high administrative costs, hidden fees, and can create unwanted tax inefficiencies.
Avoid the crowd with a low cost, individually managed Dogs of the Dow account that offers a much cleaner investment environment.
Start building a better retirement today with the Dogs of the Dow.
Sign Up Below to Receive Updates on the Dogs of the Dow, and Many Other Related Investments!
The Dogs of the Dow Portfolio has continued to generate strong levels of dividend income over time with less historical volatility, and with over over 4% in dividend income, investors can sleep easier at night.
For those that wish for more income and less volatility with the potential to grow income over time, Durig’s Dogs of the Dow Portfolio is an excellent, low cost solution with professional management and support dedicated to helping you achieve your income goals.
Durig Capital has several high yield portfolios available, click below to learn more.
Risk Disclaimer: Any content on this review should not be relied upon as advice or construed as providing recommendations of any kind. It is your responsibility to confirm and decide which trades investments to make. Invest with only with risk capital; that is, with money that, if lost, will not adversely impact your lifestyle and your ability to meet your financial obligations. Past results are no indication of future performance. In no event should the content of this correspondence be construed as an express or implied promise or guarantee.
Durig Capital is not responsible for any losses incurred as a result of this article Information provided in this correspondence is intended solely for informational purposes and is obtained from sources believed to be reliable. Information is in no way guaranteed. No guarantee of any kind is implied or possible where projections of future conditions are attempted.
Disclosure: The primary benchmark* used was SPDR® Dow Jones Industrial Avrg ETF Tr.
Only $1/clickSubmit Your Ad Here
New work has been announced pertaining to physics under collaboration with Russian and German physicists, pertaining to the behavior of electrons in atoms with different isotopes of the same element. Electrons are negative charged particles of the atom. Together, all of the electrons of an atom create a negative charge that balances the positive charge of the protons in the atomic nucleus. Electrons are very small in comparison to other parts of the atom.
This week, Durig reviews one of the largest publicly traded hospital companies in the United States. Community Health Systems (NYSE:CYH) has spent the past few years paring down its portfolio of hospitals with an eye to retain those locations that are most profitable. The results of these divestitures are starting to be seen and the company has now put up two consecutive quarters of positive growth. In its most recent quarter results, one can see that same-store metrics tell a compelling story, especially in the competitive healthcare sector (see bullets above).
A year-end performance review of Durig’s Portfolio Solutions, designed to help you earn income, covering some of the key benefits that each can provide. The following portfolios will be reviewed in this article:
- Fixed Income 2 (FX2) Managed Income Portfolio
- Dividend Aristocrats – High Dividends & Growth Over Time
- Income Aristocrats – Multi-Asset Income Portfolio
- Dogs of the Dow – High Blue Chip Dividends
- Dogs of the S&P 500 – Blue Chip Dividends
Fixed Income 2 (FX2) Managed Income Portfolio
A new study has been published pertaining to the predicting the lifespans in species. The Australian scientists from SCIRO developed the clock of lifespan. The Commonwealth Scientific and Industrial Research Organization is an Australian federal government agency responsible for scientific research. Its chief role is to improve the economic and social performance of industry for the benefit of the community. CSIRO works with leading organizations around the world. The clock allows them to calculate these of living and even dead species.
This review explores the performance of the Dogs of the Dow Portfolio, with nearly 4% in dividend income alone, and considers the many merits of blue chip dividend stocks such as those held in the portfolio.
- Year-to-Date Return of 13.03%
- Trailing 1 Year Return of 10.31%
- Annualized Return Since Inception of 14.03%
- Average Dividend Yield of 3.98%
- Alpha of 4.47 (vs. Benchmark*)
- Beta of 0.75 (vs. Benchmark*)
This week, Durig takes another look at the number two grocer in the United States. Albertsons has made a significant turnaround in the past few years after its purchase of Safeway stores in early 2015. With its most recent quarterly results, the company has now logged seven consecutive quarters of identical store sales growth. In addition, the company’s online grocery sales grew by 40% year-over-year, a massive win for this traditional brick and mortar retailer. (Other results from its Q2 results, see bullets above)
The global document outsourcing services market is segmented by services into onsite contracted services, statement printing services and document process outsourcing (DPO) services; by end-users into corporate offices, educational institutions, research institutes and others and by regions. Document Outsourcing Services Market is anticipated to mask a CAGR of 5.7% during the forecast period i.e. 2018-2027.
The Human Genome Organization (HUGO) and the European Union developed genetic information privacy regulations to protect the public. A majority of experts have agreed for the need for genetic information privacy. In 2014 the HUGO Committee on Ethics, Law and Society (CELS) presented a human rights approach to an international code of conduct for genomic and clinical data sharing. The code of conduct is supposed to prevent human rights violations during the research of genomes, allowing enough protection to allow scientific research in the genome field.
Once in a great while you find or learn something that is so unbelievably good, that you have to hear or read it over and over again, often from different sources or perspectives, before the truth of it actually starts to sink in and really make sense. Perhaps it’s that initial bewilderment that has served to curb much of any demand from the fixed income markets for this otherwise “golden” opportunity. Fortunately, this is great news for those that eventually arrive at a deeper understanding of why these Gran Colombia Gold bonds are so darn good… and it is why these bonds are well deserving of overweighting in our high performing FX2 fixed income portfolios.
Do you want more income? If your answer is yes, we have excellent news for you! Durig’s FX2 Portfolio has a lifetime track record of historical outperformance of its peer benchmarks while generating extremely high levels of fully customizable income options, something that no mutual fund can offer, all within your own separately managed account.
This week, Durig Capital takes a look at a company that provides compression services and equipment for the oil and gas industry. With the demand increasing for takeaway capacity from oil and gas fields around the country, CSI Compressco’s services become even more valuable and essential. The company had a fantastic second quarter, with record setting utilization, increased revenues and adjusted EBITDA.
Second quarter overall utilization came in at a record setting 89.1%.
Revenues increased by 36% over second quarter 2018.
Adjusted EBITDA increased 22% over first quarter and 41% year-over-year.
Outstanding interest coverage of 2.2x.
This week, Durig Capital looks at the healthcare sector to review one of the largest publicly traded hospital companies in the United States. Community Health Systems (NYSE:CYH) has spent the last few years rationalizing its portfolio of hospitals. The company is beginning to realize the effects of this strategy as evidenced by its same-store results for the second quarter (see above).
This week, Durig Capital takes a second look at an issuer involved in the design and manufacture of semiconductors. Magnachip Semiconductor (NYSE:MX) has been around for over three decades and is currently the largest independent supplier of OLED display drivers to panel makers for smartphones. The company is riding the wave of transition from LED to OLED in the smartphone world. This has paid handsomely as its full year 2018 results can attest (above). In addition, the company’s first quarter also posted continued wins for its Standard Products division.
French scientists say drinking sugary drinks such as juices and sodas may increase the risk of cancer. The results of the study were published in the British Medical Journal. The study tracked more than 100,000 people over five years. The research team at the Sorbonne-Western University in Paris speculated that sugary drinks may increase the risk of cancer because of blood sugar levels.
Beyond Belief… this may be the most fascinating debt instrument we have ever reviewed.
Rising with the price of gold, the cash flow and yield of Gran Colombia Gold’s senior secured “Gold Notes” appears to be headed straight into the land of unbelief. Perhaps what we see here is either wrong… or something in this picture seems to have quietly escaped the attention or the view of most other investors in the high yield bond market. Granted, this is not a straightforward and easily understood issue because of the quarterly interest boost linked to its amortized quarterly redemption of principle when the price of gold is higher 1250 per ounce. However, it is precisely this “hard to be understood” feature that is driving its current push into the land of dreams.
This week, Durig Capital ventures into the telecom space to look at one of the country’s major telecommunications services providers. Frontier Communications (NASDAQ: FTR) has been working hard to transform itself as cable, voice and internet usage continues to change and evolve. The company’s most recent quarter highlights some of its progress as well as actions Frontier is taking to remain competitive.
This week, Durig Capital reviews the largest underground gold and silver producer in Colombia. Gran Colombia Gold has staged an amazing transformation from just a short three years ago, when Durig Capital began to carefully follow this issuer. After completing a well-timed and skillfully crafted restructure of its balance sheet early in 2018, the company has consistently continued to smash its production targets, and has once again impressed us with its most recent results for the fourth quarter and full-year 2018.
Flow cytometry is used to monitor microscopic particles with the help of electronic devices called flow cytometers. Flow cytometry is used in stem cell research, in the development of immunology products and vaccines and also in CD4 testing.
Government initiatives in various countries is fueling growth of the environmental testing globally. In addition, with the growing demand for development of waste infrastructure the liquid chromatography-mass spectroscopy is expected to witness an upsurge in adoption in the coming years. The global liquid chromatography-mass spectroscopy market is expected to witness a growth of 7.9% CAGR over the forecast period, 2016-2024.
This week’s bond review focuses on one of the nation’s largest publicly traded hospital companies. Community Health Systems, Inc. (NYSE: CYH). CYH has spent the past few years divesting hospitals in an effort to reshape its portfolio towards urban and suburban markets. The company continues to make that shift and has now added urgent care centers in some of those markets to help drive additional patients to its hospitals. Its fourth quarter and full-year 2018 results look to be an indicator that the transformation is gaining a foothold.
Meteorology deals with the study of different weather conditions occurring in the earth’s atmosphere. The equipment used in these studies are known as meteorological equipment. These meteorological equipment are used for the measurement of different weather parameters such as humidity, temperature, pressure, net solar radiation, wind speed, precipitation (snow/rain), and cloud cover.
A thermogravimetric analyzer is that instrument which caters conduction of thermogravimetric analysis.Thermogravimetric analyzer measures mass while the temperature of the sample changes over time. Thermogravimetric analyzer consists of a precise scale fastened to a sample pan placed inside the furnace with a programmable control temperature.
MicroRNA is a tiny non-coding RNA molecule that is found in animals, plants as well as some viruses, that is utilized in post-transcriptional regulation of gene expression and RNA silencing. The overall market is likely to account for a robust growth owing to growing demand for microRNA re-agents in addition to kits for a range of applications which could in due course interpret into initial innovative therapeutic solutions for different difficult to cure illnesses. In terms of value, it is estimated to record a CAGR of 7.9% during the eight-year calculated period 2025.
Compression testers are used for testing the ability of a material to recover after a compressive external force is applied on it and the force is held on the material for a certain predefined time. The compression testers give various results such as load at rupture, maximum load on the material, deflection of material on the application of maximum load, work done at the maximum load, stiffness of material, stress on the material and strain conditions. The design of compression testers should be such that the accurate results are obtained for the particular material in case of applied compression, transverse, shear testing etc.
The compression testers market is expected to witness significant growth in next few years due to the developing industrialization. Various properties of compression testers such as accuracy, precise repeatability, and high tolerance power make them preferred in various industries in the global market.
This week’s bond review delves into the retail sector with a specialty retailer of durable consumer goods who also offers its customers financing on their purchases. Conn’s Inc., which is headquartered in Texas, has a market presence that stretches across the southern United States. Conn’s set some records in its most recent quarterly results (third quarter for its fiscal year 2019).
- Record third quarter retail gross margin of 41.2%
- Record quarterly credit segment revenues of $89.9 million.
- For the first nine months of fiscal year 2019, the company registered its second highest nine month operating income ever
- Excellent interest coverage of 2.4x.
With recent developments and improvements in video technology and image analysis software, manufacturers are focused on video extensometers to provide precise measurement for a number of specific applications.
This week, Durig Capital looks to the healthcare industry, where a medical supply logistics provider has made some key acquisitions to broaden its revenue sources. Over the past 18 months, Owens & Minor has acquired Byram Healthcare, a direct to patient medical supply distributor, along with Halyard’s surgical and infection prevention (S&IP) business. Combined, these two acquisitions are slated to add $1.45 billion in annual revenues for Owens & Minor. The company’s last reported quarterly results (third quarter 2018) show revenue growth coming through these most recent additions.
The Manual solid phase extraction process could be nerve-racking and extremely time consuming, especially due to the sample variability that results in a lack of recovery and reproducibility.
This week, Durig Capital ventures to the technology sector to review an issuer involved in the design and manufacture of semiconductors. Magnachip Semiconductor (NYSE:MX) has been around for over 30 years and is the largest independent supplier of OLED display drivers to panel makers for smartphones. The company’s latest reported quarterly results (three months ending September 30, 2018) were excellent.
Adjusted EBITDA increased 13% year-over-year.
Gross profits were up 10.8% over the prior year period.
Operating income increased by 17.9% over Q3 2017.
Revenues were up 16.6% year-over-year and were at the highest levels since Q4 2012.
Interest coverage over 3x for the third quarter.
This week, Durig Capital takes a look at a leading marine transportation company. Teekay Corporation provides marine transportation, storage, and vessel leasing for the oil and natural gas industry. The company’s third quarter saw increases in its subsidiaries revenues over second quarter. Here are some highlights from its third quarter results.
Teekay Tankers nearly doubled its quarterly revenues from the prior year period.
Teekay Corporation recorded adjusted cash flow from vessel operations of $19.8 million as compared to $1.2 million a year earlier.
Teekay LNG revenues increased to $123.3 million as compared to $104.3 million a year earlier.
This week, Durig Capital reviews a bond from an issuer that was snapped up a few years ago by one of the most enigmatic figures in corporate America. In late 2016, SolarCity was acquired by Elon Musk’s company, Tesla. The acquisition made sense- combine the maker of electric cars and energy storage with a company that produces solar panels that produce energy (seemingly to ultimately charge Tesla’s vehicles). Tesla has since integrated SolarCity’s products into the Tesla portfolio. Tesla’s most recent reported quarter (Q3 2018) was truly historical.
Free cash flow of $881 million.
Operating income of $417 million
Cash flow from operations of $1.4 billion.
Interest coverage in Q3 of 2.4x.
This week’s bond review ventures into the auto world, specifically car rentals. Hertz is one of the leading auto rental companies in the U.S. and around the world. The company recently posted its financial results for its third quarter, presenting solid evidence that the 2017 Transformation Plan is continuing to bear fruit. Some of the company’s excellent Q3 results include the following:
A 52% increase in in global net income.
U.S. adjusted corporate EBITDA increased by 25% year-over-year.
Revenues for U.S. operations also increased 10% year-over-year.
This week, Durig Capital takes a second look at an iconic cosmetic company that is continuing to refine its market strategy. Revlon, founded in 1932, has been identified with some of Hollywood’s biggest stars over the years. The company, under the direction of a new President and CEO, has recently posted some fantastic results for the third quarter including:
Adjusted operating income increased by 82% year-over-year.
A 35% increase in Adjusted EBITDA.
An increase in e-commerce sales of 23%.
Significant sales increases in China as well as North America.
This week’s bond review looks at a diversified conglomerate that has been reshaping its portfolio of companies to grow and increase synergies. Griffon Corporation has spent the past few years strengthening its business segments, particularly its Home and Building Products segment, acquiring leading brands like ClosetMaid and CornellCookson. Griffon had a fantastic third quarter. Some of the highlights include:
A 44% increase in revenues year-over-year.
Home and Building Products sales increased 59% over third quarter 2017.
Business orders for the company’s Telephonics business were up 30% year-over-year.
The Defense Electronics segment has accumulated Contract backlog of $346 million.
Durig Capital’s FX2: Bond Investing with Equity-like Returns
Stocks versus bonds – which is the better investment? This is a highly individual question and depends on the goals of the investor. For most investors, getting the best return with the least amount of risk is a goal worth striving for. But what is the best way to do this? While stocks have generally outperformed bonds, there are exceptions to the rule. Consider Durig Capital’s FX2 Managed Income Portfolio.
This portfolio’s 3-year trailing return has handily beat the S&P 500 index.
Not only has its returns exceeded that of the S&P 500 index, it has done so with roughly half the risk (volatility).
Morningstar claimed that FX2 was the top performing Fixed Income SMA among its peer group in the last significant interest rate spike of 2016.
Additionally, Morningstar has ranked Durig Captial’s FX2 portfolio as the top performing Fixed Income SMA for Trailing 1-year, 3-year, and 5-year returns, as well as for Q1 and Q2 of 2018, amongst a peer group of over 800 SMA’s.
Informa ranked FX2 1st in performance in 1,2,3 and 5 year return categories, as well as since inception, as compared to its peers in Short-Term Fixed Income.
Durig’s FX2 Portfolio – Third Quarter Rankings from Informa
Informa Investment Solutions Bench Ranked 1st in Performance Durig Capital’s Fixed Income 2 (FX2) Portfolio against its peer group of short term fixed income in it’s PSN database.
Here is how Durig’s FX2 Portfolio was Ranked Third Quarter of 2018:
Durig Capital Rank
Number of Competitors
This week, Durig Capital looks to the skies as it reviews an issuer that is focused on the design and manufacture of aircraft parts and systems. Triumph Group has spent the past few years shedding non-core business assets, consolidating locations and streamlining its operations with an eye to cost reductions. Its latest quarterly results showcase its progress on this journey. Its fiscal year 2019 first quarter results included the following:
A 6.5% increase in net sales as compared to Q1 FY 2018
An increase of 126% in adjusted EBITDA as compared to the prior year period.
Interest coverage was an outstanding 2.3x for Q1
Triumph Group is projecting a 5% increase in net sales in FY 2019.
Backlog increased by 5% over the previous year period.
Diversification is the word this week as Durig Capital takes a second look at the number two grocer in the United States. Albertsons recently posted its first quarter results for fiscal year 2018. The company showcased some impressive financials including the following:
Adjusted EBITDA of $815.8 million, an increase of 5.7% year-over-year.
39% increase in net cash provided by operating activities.
108% increase in e-commerce sales.
Interest coverage of nearly 3x.
Market Research Future’s (MRFR) latest study reveals that the global vehicle anti-theft market is set to exhibit a substantial growth at a moderate pace over the forecast period 2016 to 2022. The technological advancements adopted by the vehicle anti-theft industry leaders is expected to catapult the market on an upward trajectory for the next few years.
The boom witnessed in the automotive sector has a direct and a positive influence on the growth of the vehicle anti-theft market. The increasing demand for automobiles equipped with vehicle anti-theft technologies is projected to fuel demand for vehicle anti-theft security solutions through the assessment period.
This week’s bond issuer is a company entrenched in production and transportation of natural gas. CSI Compressco’s (CCLP) first and second quarters have been outstanding, both recording consecutive increases in revenues. The oil and gas industry’s activity level has been steadily increasing over the past 18 months and CCLP has started to see the effects of this on all three of its business segments – Compression Services, Aftermarket Services, and Equipment Sales. Its second quarter results gives investors reason to look twice at this natural gas services company.
Q2 revenues increased 33% year-over-year, and 17% over Q1 2018.
Adjusted EBITDA increased 21% over Q1 and 19% year-over-year.
Compressions Services increased gross margin by 460 basis points.
At the conclusion of Q2, new equipment sales had generated a backlog of $102 million, revenue to be recognized later this year and the first half of 2019.
Durig’s FX2 Portfolio – Helping to Solve Your Income Needs
Performance Review of Durig’s FX2 Portfolio
- Morningstar’s Top Performing Fixed Income SMA in Trailing 1, 3 & 5 Year Returns, Q1 2018, Q2 2018
- Up 10.94% YTD
- Up 12.64% Trailing 1 Year Return
- Up 17.54% Trailing 3 Year Return
- Up 9.59% Trailing 5 Year Return
This week, Durig Capital takes a look at an oil and gas producer who has balanced its revenue streams between oil, natural gas and natural gas liquids (NGLs). Approach Resources has posted excellent results the past two quarters and has some unique advantages amongst oil and gas producers – significant, contiguous acreage, 100% owned infrastructure, improved well recovery and a balanced product portfolio. It’s most recent quarter continued the positive trend set in Q1.
A 21% increase in revenues year-over-year.
Production increases over Q1 by 2%, at the high end of quarterly guidance.
18% increase in EBITDAX.
Interest coverage of 2.7x.
Performance Review of Durig Capital’s Fixed Income 2 (FX2) Managed Income Portfolio
Up 9.70% YTD
Up 16.91% Trailing 1 Year Return
Up 15.09% Trailing 3 Year Return
Up 9.61% Trailing 5 Year Return